Recce Pharmaceuticals Ltd (ASX:RCE)

Recce Pharmaceuticals Revenue

In the fiscal year ending June 30, 2025, Recce Pharmaceuticals had annual revenue of 7.51M AUD with 49.33% growth. Recce Pharmaceuticals had revenue of 562.52K in the half year ending June 30, 2025, a decrease of -87.11%.

• Revenue: 7.51M
• Revenue Growth: +49.33%
• P/S Ratio: 16.18
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 121.46M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	7.51M	2.48M	49.33%
Jun 30, 2024	5.03M	663.14K	15.19%
Jun 30, 2023	4.37M	1.28M	41.50%
Jun 30, 2022	3.08M	1.45M	88.41%
Jun 30, 2021	1.64M	515.66K	45.97%